Best Anthracycline Topoisomerase Inhibitor for leukemia, myelogenous, chronic, bcr-abl positive
The 2 Anthracycline Topoisomerase Inhibitor options we list for leukemia, myelogenous, chronic, bcr-abl positive are all Idarubicin Hydrochloride— the same active ingredient in different brands or formulations, so they aren’t ranked against each other on effectiveness. Our score reflects each product’s FDA recall-safety record; the practical choice is brand vs generic, dose, and cost. Compare them with all treatments for leukemia, myelogenous, chronic, bcr-abl positive or the full Anthracycline Topoisomerase Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 2 anthracycline topoisomerase inhibitor drugs we rate for leukemia, myelogenous, chronic, bcr-abl positive, none are yet flagged as generics in our price data, and most are injectable. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for leukemia, myelogenous, chronic, bcr-abl positive; the right choice depends on your situation, so confirm it with your prescriber.
How anthracycline topoisomerase inhibitor work
These chemotherapy drugs slip between the strands of a cancer cell's DNA and jam an enzyme called topoisomerase II that the cell needs to copy its DNA. This leaves the DNA broken and unrepairable, so the cancer cell stops dividing and dies.
Other drug classes for leukemia, myelogenous, chronic, bcr-abl positive
These are all Idarubicin Hydrochloridein different brands or formulations, so we don’t rank them against each other — the list below is for comparing brand vs generic, dose, and typical cost, not for picking a “best” one on effectiveness.
All 2 anthracycline topoisomerase inhibitor products
idarubicin hydrochloride
Boxed warningPrescriptionFDA-sourced
Idarubicin Hydrochloride is an anthracycline topoisomerase inhibitor used to treat Breast Neoplasms, Bcr-Abl Positive Chronic Myelogenous Leukemia, Acute Myeloid Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Price varies
idamycin pfs
Boxed warningPrescriptionFDA-sourced
Idamycin Pfs (Idarubicin Hydrochloride) is an anthracycline topoisomerase inhibitor used to treat Breast Neoplasms, Bcr-Abl Positive Chronic Myelogenous Leukemia, Acute Myeloid Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Price varies
Frequently asked
- What is the best anthracycline topoisomerase inhibitor for leukemia, myelogenous, chronic, bcr-abl positive?
- The Anthracycline Topoisomerase Inhibitor options we list for leukemia, myelogenous, chronic, bcr-abl positive are all Idarubicin Hydrochloride — the same active ingredient in different brands or formulations — so there's no single "best" one on effectiveness; the practical choice is brand vs generic, dose, and cost. Always consult a professional.
- Which anthracycline topoisomerase inhibitor drugs treat leukemia, myelogenous, chronic, bcr-abl positive?
- pharmaranks lists 2 Anthracycline Topoisomerase Inhibitor products used for leukemia, myelogenous, chronic, bcr-abl positive, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.